IL MINN

IL MINN

Johns Hopkins University

H-index: 32

North America-United States

About IL MINN

IL MINN, With an exceptional h-index of 32 and a recent h-index of 26 (since 2020), a distinguished researcher at Johns Hopkins University,

His recent articles reflect a diverse array of research interests and contributions to the field:

A third generation PSMA-targeted agent [211At] YF2: Synthesis and in vivo evaluation

Prostate-specific membrane antigen (psma)-targeted prodrug for selective killing of cells expressing psma

Imaging brain injury in former National Football League players

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy

First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2

Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods

Glucose triptolide conjugates and uses thereof

IL MINN Information

University

Position

___

Citations(all)

3448

Citations(since 2020)

2198

Cited By

2097

hIndex(all)

32

hIndex(since 2020)

26

i10Index(all)

52

i10Index(since 2020)

49

Email

University Profile Page

Google Scholar

Top articles of IL MINN

A third generation PSMA-targeted agent [211At] YF2: Synthesis and in vivo evaluation

Nuclear Medicine and Biology

2024/5/1

Prostate-specific membrane antigen (psma)-targeted prodrug for selective killing of cells expressing psma

Nanotheranostics

2021

Imaging brain injury in former National Football League players

JAMA Network Open

2023/10/2

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Molecules

2023/8/21

Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy

2023/7/11

First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2

European Journal of Nuclear Medicine and Molecular Imaging

2023/7

Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods

2023/6/22

Glucose triptolide conjugates and uses thereof

2023/5/4

93. Imaging the Neuroimmune Response After Repeated Traumatic Brain Injury

Biological Psychiatry

2023/5/1

Il Minn
Il Minn

H-Index: 21

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

bioRxiv

2023

Correction to: Hetero-bivalent agents targeting FAP and PSMA

European Journal of Nuclear Medicine and Molecular Imaging

2022/11/1

Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma

Science Advances

2022/7/20

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents

Biomolecules

2022/3/5

A unique core–shell structured, glycol chitosan-based nanoparticle achieves cancer-selective gene delivery with reduced off-target effects

Pharmaceutics

2022/2/7

Bei Cheng
Bei Cheng

H-Index: 5

Il Minn
Il Minn

H-Index: 21

An improved 211At-labeled agent for PSMA-targeted α-therapy

Journal of Nuclear Medicine

2022/2/1

Compositions of nucleic acid-containing nanoparticles for in vivo delivery

2022/2/1

Competitive prostate-specific membrane antigen (psma) binding agents for reduction of non-target organ uptake of radiolabeled psma inhibitors for psma positive tumor imaging …

2021/11/4

PSMA-based molecular-genetic reporter system

2021/9/21

First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET

European journal of nuclear medicine and molecular imaging

2021/9

Non-invasive delivery of levodopa-loaded nanoparticles to the brain via lymphatic vasculature to enhance treatment of Parkinson’s disease

Nano Research

2021/8

See List of Professors in IL MINN University(Johns Hopkins University)